[
  {
    "variant_string_id": "EGFR L858R",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper focuses on the role of EGFR mutations, including L858R, in the pathogenesis of non-small cell lung cancer (NSCLC). EGFR mutations activate downstream signaling pathways that promote cell proliferation and survival.",
        "judgment": "Yes",
        "reasoning": "The paper explicitly links EGFR mutations to cancer development and describes their functional consequences."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The study employs an enzyme activity assay to evaluate the impact of the L858R mutation on EGFR kinase activity. This assay directly assesses the altered functionality of the protein, which is fundamental to disease mechanism.",
        "judgment": "Yes",
        "reasoning": "Measuring kinase activity aligns with the understanding of how EGFR mutations drive cancer progression.",
        "next_step_or_outcome": "Proceed to Step 1a"
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "N/A"
    },
    "overall_conclusion": "The study aims to demonstrate the pathogenic effect of the L858R mutation through a direct measure of enzyme activity."
  }
]